Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Fluorinated Analog NMR s of Organosulfur Compounds from Garlic (Allium sativum): Synthesis, Chemistry and Anti-Angiogenesis and Antithrombotic Studies.

Block E, Bechand B, Gundala S, Vattekkatte A, Wang K, Mousa SS, Godugu K, Yalcin M, Mousa SA.

Molecules. 2017 Nov 28;22(12). pii: E2081. doi: 10.3390/molecules22122081.

2.

Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration.

Thomas M, Mousa SS, Mousa SA.

Clin Ophthalmol. 2013;7:495-501. doi: 10.2147/OPTH.S29974. Epub 2013 Mar 8.

4.

Current status of vascular endothelial growth factor inhibition in age-related macular degeneration.

Mousa SA, Mousa SS.

BioDrugs. 2010 Jun;24(3):183-94. doi: 10.2165/11318550-000000000-00000. Review.

PMID:
20210371
5.

Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.

Yalcin M, Bharali DJ, Dyskin E, Dier E, Lansing L, Mousa SS, Davis FB, Davis PJ, Mousa SA.

Thyroid. 2010 Mar;20(3):281-6. doi: 10.1089/thy.2009.0249.

PMID:
20187783
6.

High Density Lipoprotein (HDL) Modulation Targets.

Mousa SS, Block RC, Mousa SA.

Drugs Future. 2010 Jan;35(1):33-39.

7.

Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA).

Mousa SS, Davis FB, Davis PJ, Mousa SA.

Clin Appl Thromb Hemost. 2010 Jun;16(3):288-93. doi: 10.1177/1076029609348315. Epub 2009 Nov 10.

PMID:
19903697
8.

The multiple faces of nicotine and its implications in tissue and wound repair.

Martin JW, Mousa SS, Shaker O, Mousa SA.

Exp Dermatol. 2009 Jun;18(6):497-505. doi: 10.1111/j.1600-0625.2009.00854.x. Review.

PMID:
19492997
9.

Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine.

Avery P, Mousa SS, Mousa SA.

Pharmgenomics Pers Med. 2009;2:79-91. Epub 2009 Sep 13.

10.

Pharmacogenomics in osteoporosis: Steps toward personalized medicine.

Greene R, Mousa SS, Ardawi M, Qari M, Mousa SA.

Pharmgenomics Pers Med. 2009;2:69-78. Epub 2009 Sep 10.

11.

Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine.

Barone C, Mousa SS, Mousa SA.

Pharmgenomics Pers Med. 2009;2:59-67. Epub 2009 Sep 8.

12.

Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder.

Brady C, Mousa SS, Mousa SA.

Drug Healthc Patient Saf. 2009;1:9-15. Epub 2009 Feb 3.

13.

Supplemental Content

Loading ...
Support Center